Article info
PDFOriginal article
Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma
- Correspondence to Professor Vani Santosh, Neuropathology, National Institute Of Mental Health and Neurosciences (NIMHANS), Bangalore 560029, Karnataka, India; vani.santosh{at}gmail.com
Citation
Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma
Publication history
- Received March 10, 2019
- Revised June 5, 2019
- Accepted June 7, 2019
- First published July 3, 2019.
Online issue publication
September 19, 2019
Article Versions
- Previous version (3 July 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.